Inactief instrument

Andere talen Affymax, Inc. Nasdaq

Aandelen

US00826A1097

slotkoers Nasdaq Andere beurzen
- ^USD	-

2013	Transcript : Affymax, Inc. - Special Call
2013	Transcript : Affymax, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-10-2013 01:00 PM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer	26-11-14
Affymax Seeks Acquisitions	26-11-14
Affymax, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2014	31-07-14
Affymax Terminates Omontys' Product Collaboration and License Agreement with Takeda Pharmaceutical Company, Effective September 10, 2014	16-06-14
Affymax and Takeda Announce Termination of Omontys(R) (peginesatide) Product Collaboration and License Agreement	13-06-14
Affymax To Review Strategic Options	13-06-14
Affymax, Inc. Auditor Raises 'Going Concern' Doubt	31-03-14
Affymax, Inc. Executes a Seventh Amendment to Lease Agreement	20-08-13
Affymax, Inc. Announces Management Changes	07-06-13
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Composite Index	05-06-13
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Biotechnology Index	19-05-13
Affymax, Inc. to Terminate John Orwin as Chief Executive Officer After May 15, 2013	15-05-13
Affymax, Inc. to Reduce Workforce Amid Product Investigation	24-04-13
Affymax, Inc. Enters into a Letter Agreement with Oxford Finance Corporation and Silicon Valley Bank	04-04-13
Affymax, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012	02-04-13
Affymax, Inc. Auditor Raises 'Going Concern' Doubt	02-04-13
Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation	18-03-13
Affymax, Inc. may file for Bankruptcy	18-03-13
Affymax Seeks Strategic Alternatives	18-03-13
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection	25-02-13

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Affymax, Inc. Nasdaq

Aandelen

US00826A1097

Andere talen

Filters